{"disease":{"id":"pulmonary-atresia-with-ventricular-septal-defect","name":"pulmonary atresia with ventricular septal defect"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04452188","title":"Targeting Normoxia in Neonates With Cyanotic Congenital Heart Disease in the Intra-operative and Immediate Post-operative Period","phase":"NA","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"University of Michigan","has_results":true},{"nct_id":"NCT02861963","title":"Choice of Palliative Procedures for Pulmonary Atresia With Ventricular Septal Defect Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Meshalkin Research Institute of Pathology of Circulation","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}